[Establishment of Hematopoietic cell transplantation program in developing countries : Guidelines from the francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)].

Yafour N, Bekadja MA, Chevallier P, Cabrera Q, Coman T, Elkababri M, Hamzy F, Quessar A, Laamiri A, Pochon C, Yakoub-Agha I, Harif M

Open source

DOI
10.1016/j.bulcan.2021.02.015
Published
2021 Dec
Container
Bulletin du cancer
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.bulcan.2021.02.015,
  title = {[Establishment of Hematopoietic cell transplantation program in developing countries : Guidelines from the francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)].},
  author = {Yafour N and Bekadja MA and Chevallier P and Cabrera Q and Coman T and Elkababri M and Hamzy F and Quessar A and Laamiri A and Pochon C and Yakoub-Agha I and Harif M},
  year = {2021},
  journal = {Bulletin du cancer},
  doi = {10.1016/j.bulcan.2021.02.015},
  url = {https://doi.org/10.1016/j.bulcan.2021.02.015}
}

RIS

TY  - JOUR
TI  - [Establishment of Hematopoietic cell transplantation program in developing countries : Guidelines from the francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)].
AU  - Yafour N
AU  - Bekadja MA
AU  - Chevallier P
AU  - Cabrera Q
AU  - Coman T
AU  - Elkababri M
AU  - Hamzy F
AU  - Quessar A
AU  - Laamiri A
AU  - Pochon C
AU  - Yakoub-Agha I
AU  - Harif M
PY  - 2021
JO  - Bulletin du cancer
DO  - 10.1016/j.bulcan.2021.02.015
UR  - https://doi.org/10.1016/j.bulcan.2021.02.015
ER  - 

APA

N, Y., MA, B., P, C., Q, C., T, C., M, E., F, H., A, Q., A, L., C, P., I, Y., & M, H. (2021). [Establishment of Hematopoietic cell transplantation program in developing countries : Guidelines from the francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)].. Bulletin du cancer. https://doi.org/10.1016/j.bulcan.2021.02.015

Source records